Revenue Growth - FY 2024 revenue increased 32.9% year over year to $28.34 million, up from $21.33 million in FY 2023[5] - Revenue from direct patient services segment surged 253.4% year over year to $12.56 million, compared to $3.55 million in FY 2023[5] - Q4 2024 revenue increased 59.2% to $9.07 million compared to $5.70 million in Q4 2023, driven by expanded radiation therapy services[11] - Q4 2024 revenue from direct patient services segment was $4.75 million, a 420.2% increase from the same period last year[12] Net Income and Earnings - Net income attributable to the company for FY 2024 rose 258.4% to $2.19 million, or $0.34 per diluted share, compared to $610,000, or $0.10 per diluted share in FY 2023[9] - The overall net income for the twelve months ended December 31, 2024, was $2,186,000, compared to $610,000 in 2023, representing an increase of approximately 258.7%[28] Adjusted EBITDA - Adjusted EBITDA for FY 2024 increased 8.5% to $8.89 million from $8.19 million in FY 2023[10] - Adjusted EBITDA for the twelve months ended December 31, 2024, was $8,885,000, up from $8,189,000 in 2023, reflecting a year-over-year increase of approximately 8.5%[28] Cash and Equity - Cash, cash equivalents, and restricted cash totaled $11.28 million as of December 31, 2024, down from $13.81 million a year earlier[16] - Shareholders' equity increased to $25.18 million or $3.92 per outstanding share at December 31, 2024, compared to $22.62 million or $3.59 per share at December 31, 2023[16] Expenses and Losses - Interest expense increased to $1,499,000 for the twelve months ended December 31, 2024, compared to $1,112,000 in 2023, representing a rise of about 34.8%[28] - Depreciation and amortization expense for the three months ended December 31, 2024, was $1,673,000, an increase from $1,291,000 in the same period of 2023, showing a growth of approximately 29.6%[28] - Loss on write down of impaired assets and associated removal costs for the three months ended December 31, 2024, was $2,896,000, compared to $362,000 in the same period of 2023, indicating a substantial increase[28] Tax and Interest Income - Income tax benefit for the three months ended December 31, 2024, was $(71,000), a decrease from $338,000 in 2023, reflecting a change in tax position[28] - Interest income for the twelve months ended December 31, 2024, was $(342,000), down from $(458,000) in 2023, indicating a decrease of approximately 25.3%[28] Stock-Based Compensation and Gains - Stock-based compensation expense for the twelve months ended December 31, 2024, was $373,000, slightly down from $389,000 in 2023, showing a decrease of about 4.1%[28] - The company reported a bargain purchase gain of $(148,000) for the three months ended December 31, 2024, compared to no gain in the same period of 2023[28]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM _________ to __________ COMMISSION FILE NUMBER 001-41719 60 DEGREES PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) | Delaware | ...

or ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Table of Contents United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2025 Commission File Number 0-10843 CSP Inc. (Exact name of Registrant as specified in its charter) Massachusetts 04-2441294 (State or other jurisdicti ...

As filed with the Securities and Exchange Commission on May 15, 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT T ...

Financial Performance - Net sales decreased by 8.2% to $3.571 million for the three months ended March 31, 2025, from $3.890 million for the same period in 2024 due to higher one-time sales in the prior year [106]. - Net sales for the nine months ended March 31, 2025, decreased by $1.526 million or 8.2% to $12.264 million from $13.790 million for the same period in 2024 [117]. - Net loss reduced to $(0.240) million for the three months ended March 31, 2025, from a net loss of $(0.601) million for the same period in 2024, reflecting a loss reduction of $0.361 million [115]. - Net loss improved by $0.164 million to $(0.792) million for the nine months ended March 31, 2025, driven by higher gross margin and lower operating expenses [127]. Profitability - Gross profit increased by $0.387 million or 57.2% to $1.063 million for the three months ended March 31, 2025, with gross profit percentage rising to 29.8% from 17.4% [108]. - Gross profit for the nine months ended March 31, 2025, increased to $3.370 million from $3.254 million for the same period in 2024 [118]. - Gross profit increased by $0.116 million or 3.6% to $3.370 million for the nine months ended March 31, 2025, with gross profit percentage rising to 27.5% from 23.6% [119]. Expenses - Research and development expenses decreased by $0.024 million or 33% to $0.049 million for the three months ended March 31, 2025, compared to $0.073 million for the same period in 2024 due to headcount reduction [110]. - Research and development expenses decreased by $0.055 million or 25.9% for the nine months ended March 31, 2025, due to headcount reduction [121]. - Selling, general and administrative expenses increased by $0.032 million or 2.6% to $1.284 million for the three months ended March 31, 2025, compared to $1.252 million for the same period in 2024 [112]. - Selling, general and administrative expenses decreased by $0.026 million or 0.6% for the nine months ended March 31, 2025, attributed to headcount reduction and lower compensation expenses [123]. - Other income decreased by $0.033 million to $0.107 million for the nine months ended March 31, 2025, due to lower interest income on cash savings accounts [125]. Cash Flow and Liquidity - Cash balance at March 31, 2025, was approximately $5.369 million, an increase from $5.278 million at June 30, 2024 [128]. - Net cash provided by operating activities increased by $0.415 million to $0.091 million for the nine months ended March 31, 2025, primarily due to cost reductions [129]. - Net cash used in investing activities was zero for the nine months ended March 31, 2025, compared to $(0.012) million for equipment purchases in the prior year [131]. - Net cash provided by financing activities was zero for the nine months ended March 31, 2025, compared to $(0.334) million used for share repurchases in the prior year [132]. - Company believes existing sources of liquidity will be sufficient to fund operations for at least 12 months from the date of financial statement issuance [128]. Strategic Initiatives - The company plans to invest in sales and support operations to support new product initiatives and budget goals [96]. - The company aims to increase marketing expenditures to enhance brand recognition for its proprietary product line [98]. - The company expects to maintain gross margins despite competition and pricing pressures by focusing on increased sales volume and introducing new products with higher gross margins [99].

Revenue Performance - Revenue for the quarter ended March 31, 2025, was RMB236,454 million (US$32,584 million), an increase of 7% year-over-year[4]. - Revenue from the Cloud Intelligence Group increased by 18% year-over-year to RMB30,127 million (US$4,152 million), with AI-related product revenue maintaining triple-digit growth for the seventh consecutive quarter[15][16]. - Revenue from the Digital Media and Entertainment Group increased by 12% year-over-year to RMB5,554 million (US$765 million), driven by strong performance in the movie and entertainment sectors[21]. - Revenue from the International commerce retail business grew by 24% year-over-year to RMB27,603 million (US$3,804 million), primarily due to contributions from AliExpress and Trendyol[37]. - Revenue from the Local Services Group rose by 10% year-over-year to RMB16,134 million (US$2,223 million), supported by growth in Amap and Ele.me[44]. - Total revenue for fiscal year 2025 was RMB996,347 million (US$137,300 million), representing a 6% year-over-year increase from RMB941,168 million in fiscal year 2024[79]. - Revenue from the Taobao and Tmall Group for fiscal year 2025 was RMB449,827 million (US$61,988 million), a 3% increase from RMB434,893 million in fiscal year 2024[83]. - Revenue from the Alibaba International Digital Commerce Group increased by 29% to RMB132,300 million (US$18,231 million) in fiscal year 2025, driven by growth in AliExpress and Trendyol[83]. - Digital Media and Entertainment Group revenue increased by 5% to RMB22,267 million (US$3,068 million) in fiscal year 2025, up from RMB21,145 million in fiscal year 2024[100]. - Revenue from All Others segment rose by 7% to RMB206,269 million (US$28,425 million) in fiscal year 2025, compared to RMB192,331 million in fiscal year 2024[102]. Profitability Metrics - Net income attributable to ordinary shareholders was RMB12,382 million (US$1,706 million), with net income increasing by 1203% year-over-year to RMB11,973 million (US$1,650 million)[4]. - Income from operations increased by 93% year-over-year to RMB28,465 million (US$3,923 million), primarily due to increased adjusted EBITA and decreased non-cash share-based compensation[4]. - Adjusted EBITDA for the quarter was RMB41,783 million (US$5,758 million), reflecting a 36% increase compared to RMB30,807 million in the same quarter of 2024[29]. - Net income for the quarter was RMB11,973 million (US$1,650 million), a significant increase from RMB919 million in the same quarter of 2024[69]. - Net income for fiscal year 2025 was RMB125,976 million (US$17,360 million), a significant increase of 77% compared to RMB71,332 million in fiscal year 2024[79]. - Non-GAAP net income increased by 22% year-over-year to RMB29,847 million (US$4,113 million), compared to RMB24,418 million in the same quarter of 2024[70]. - Net income attributable to Alibaba Group Holding Limited for the year ended March 31, 2025, was RMB130,109 million, a significant increase of 63% compared to RMB80,009 million in 2024[156]. Cash Flow and Investments - Free cash flow for the quarter was RMB3,743 million (US$516 million), a decrease of 76% compared to RMB15,361 million in the same quarter of 2024[5]. - For the quarter ended March 31, 2025, net cash provided by operating activities was RMB27,520 million (US$3,792 million), an increase of 18% compared to RMB23,340 million in the same quarter of 2024[75]. - Free cash flow for fiscal year 2025 was RMB73,870 million (US$10,180 million), a significant decrease of 53% from RMB156,210 million in fiscal year 2024[131]. - Net cash used in investing activities was RMB185,415 million (US$25,551 million), primarily due to an increase in other treasury investments by RMB126,041 million (US$17,369 million)[132]. - Net cash used in financing activities amounted to RMB76,215 million (US$10,502 million), reflecting cash used for share repurchases of RMB86,662 million (US$11,942 million) and dividend payments of RMB29,077 million (US$4,007 million)[133]. Shareholder Returns - The board approved a total dividend of approximately US$4.6 billion, including an annual and a special dividend[23]. - During fiscal year 2025, the company repurchased US$11.9 billion of shares, achieving a 5.1% net reduction in outstanding shares[3][22]. Cost Management - Cost of revenue decreased to RMB145,626 million (US$20,068 million), or 61.6% of revenue, down from 66.7% in the same quarter of 2024, primarily due to improved monetization and operating efficiency[51][60]. - Total costs and expenses increased to RMB856,203 million (US$117,988 million) in fiscal year 2025, up from RMB827,818 million in fiscal year 2024[104]. - Cost of revenue as a percentage of revenue decreased from 62.3% in fiscal year 2024 to 60.0% in fiscal year 2025, with a nominal increase in cost from RMB586,323 million to RMB598,285 million[105]. Employee Metrics - The number of employees decreased to 124,320 as of March 31, 2025, down from 194,320 as of December 31, 2024, mainly due to the sale and deconsolidation of Sun Art[78]. - The total number of employees decreased to 124,320 as of March 31, 2025, from 204,891 a year earlier, mainly due to the sale and deconsolidation of Sun Art[134]. Future Outlook - The company aims to build the future infrastructure of commerce, envisioning a long-term presence of 102 years[138]. - Forward-looking statements indicate potential risks and uncertainties that could affect future performance, including competition and geopolitical tensions[140].

Financial Performance - Gross transaction value (GTV) increased by 34.0% year-over-year to RMB843.7 billion (US$116.3 billion) in Q1 2025, with existing home transactions growing by 28.1% to RMB580.3 billion (US$80.0 billion) and new home transactions rising by 53.0% to RMB232.2 billion (US$32.0 billion) [8]. - Net revenues reached RMB23.3 billion (US$3.2 billion), marking a 42.4% increase year-over-year, driven by growth in both existing and new home transaction services [12]. - Net income for Q1 2025 was RMB855 million (US$118 million), a significant increase of 97.9% year-over-year, while adjusted net income remained relatively flat at RMB1,393 million (US$192 million) [8]. - Total net revenues for the three months ended March 31, 2025, increased to RMB 23,328,347, representing a 42.5% growth compared to RMB 16,377,314 for the same period in 2024 [56]. - Net income attributable to KE Holdings Inc. for the three months ended March 31, 2025, was RMB 855,767, up from RMB 431,774 in the same period of 2024, reflecting a 98.1% increase [57]. Revenue Breakdown - Net revenues from existing home transaction services were RMB6.9 billion (US$0.9 billion), up 20.0% year-over-year, while new home transaction services saw revenues of RMB8.1 billion (US$1.1 billion), a 64.2% increase [12]. - The company reported a significant increase in new home transaction services revenue, which rose to RMB 8,074,995 for the three months ended March 31, 2025, up from RMB 4,916,515 in the same period of 2024, marking a 64.4% increase [56]. - Net revenues from existing home transaction services reached RMB 6,870,407, up from RMB 5,727,030, representing a growth of approximately 20% [64]. - New home transaction services generated net revenues of RMB 8,074,995, a substantial increase from RMB 4,916,515, marking a growth of about 64% [64]. - The contribution from home renovation and furnishing services increased to RMB 959,487, compared to RMB 737,130, reflecting a growth of approximately 30% [64]. Operational Metrics - The number of active stores increased by 29.6% year-over-year to 55,210, and the number of active agents rose by 23.0% to 490,862 as of March 31, 2025 [8]. - Mobile monthly active users (MAU) averaged 44.5 million in Q1 2025, a decrease from 47.7 million in the same period of 2024 [9]. - Income from operations was RMB591 million (US$81 million) in Q1 2025, a significant increase from RMB12 million in Q1 2024, resulting in an operating margin of 2.5% compared to 0.1% in the same period last year [24]. - Adjusted income from operations was RMB1,148 million (US$158 million) in Q1 2025, up from RMB960 million in Q1 2024, with an adjusted operating margin of 4.9% compared to 5.9% in the same period last year [25]. Expenses and Costs - Total cost of revenues increased by 51.0% to RMB18.5 billion (US$2.6 billion) in Q1 2025, primarily due to higher costs associated with increased transaction volumes [17]. - General and administrative expenses decreased to RMB1.9 billion (US$0.3 billion) in Q1 2025 from RMB2.0 billion in Q1 2024, primarily due to reduced share-based compensation expenses [29]. - Research and development expenses rose by 24.9% to RMB584 million (US$80 million) in Q1 2025 from RMB467 million in Q1 2024, driven by increased headcount and technical service costs [29]. Shareholder Returns - The company allocated approximately US$139 million to share repurchases in Q1 2025, representing about 0.6% of total issued shares at the end of 2024 [13]. - The company has repurchased approximately 116.6 million ADSs (representing about 349.9 million Class A ordinary shares) for a total consideration of approximately US$1,764.8 million under its share repurchase program since its launch [37]. - The company plans to continue its share repurchase program until August 31, 2025, subject to obtaining a new mandate from shareholders [37]. Cash and Assets - As of March 31, 2025, the combined balance of cash, cash equivalents, restricted cash, and short-term investments was RMB54.8 billion (US$7.6 billion) [34]. - Cash and cash equivalents as of March 31, 2025, were RMB 12,772,700, an increase from RMB 11,442,965 as of December 31, 2024 [53]. - Total assets decreased slightly to RMB 130,612,461 as of March 31, 2025, from RMB 133,149,283 as of December 31, 2024 [55]. - Total current liabilities remained stable at RMB 52,761,664 as of March 31, 2025, compared to RMB 52,744,258 as of December 31, 2024 [54]. - Total shareholders' equity decreased to RMB 68,951,339 as of March 31, 2025, from RMB 71,447,995 as of December 31, 2024 [55]. Earnings Per Share - Basic and diluted net income per ADS attributable to ordinary shareholders was RMB0.76 (US$0.10) and RMB0.73 (US$0.10) in Q1 2025, compared to RMB0.38 and RMB0.37 in Q1 2024, respectively [32]. - Adjusted net income attributable to ordinary shareholders was RMB1,393 million (US$192 million) in Q1 2025, relatively flat compared to RMB1,392 million in Q1 2024 [30]. - The weighted average number of ordinary shares used in computing net income per share, basic, was 3,362,716,016 for the three months ended March 31, 2025 [58]. - The weighted average number of ADS used in computing net income per ADS, diluted, was 1,174,000,690 for the three months ended March 31, 2025 [60]. Cash Flow - The company experienced a net cash used in operating activities of RMB 3,965,271, an increase from RMB 2,108,532 in the prior year, indicating higher operational expenditures [62]. - The company’s cash, cash equivalents, and restricted cash at the end of the period were RMB 22,918,385, down from RMB 24,783,312 at the beginning of the period [62]. - Adjusted EBITDA for the three months ended March 31, 2025, was RMB 1,841,720, an increase from RMB 1,665,669 in the previous year [59].

Exhibit 99.1 bioAffinity Technologies Reports First Quarter 2025 Results CyPathLung sales up 276% year-over-year SAN ANTONIO, Texas (May 15, 2025) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for accurate, noninvasive tests for the detection of early-stage lung cancer and other lung diseases, today reported financial results for the three months ended March 31, 2025. Key Highlights Management Commentary "We began 2025 with strong momentum, delivering 27 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 ...

Revenue Performance - Revenue for the three months ended March 31, 2025, was $12,003, a decrease of 84.7% compared to $78,739 for the same period in 2024[53][61] Cost and Expenses - Cost of revenue for the three months ended March 31, 2025, was $30,862, down 55.1% from $68,498 in the same period in 2024[62] - Research and development expenses increased by $201,099, or 15%, to $1,567,992 for the three months ended March 31, 2025, compared to $1,366,893 in 2024[63] - General and administrative expenses rose by $46,133, or 5%, to $899,821 for the three months ended March 31, 2025, from $853,688 in 2024[64] - Sales and marketing expenses increased by $21,549, or 7%, to $338,160 for the three months ended March 31, 2025, compared to $316,611 in 2024[65] Operational Loss - Loss from operations for the three months ended March 31, 2025, was $2,824,832, a 12% increase from the loss of $2,526,951 in 2024[66] - Net loss for the three months ended March 31, 2025, was $2,703,024, a 9% increase from the net loss of $2,469,626 in 2024[67] Financial Position - Cash and cash equivalents at March 31, 2025, were $13.7 million, with net working capital of $13.4 million[68] Cash Flow - Operating activities resulted in cash outflows of $2,066,774 for the three months ended March 31, 2025, compared to $1,875,295 in 2024[70][71] Interest Income - Net interest income for the three months ended March 31, 2025, was $121,808, compared to $57,325 in the same period in 2024[67]